Arax Advisory Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.32M | Buy |
22,382
+15,758
| +238% | +$3.27M | 0.04% | 468 |
|
|
2026
Q1 | $1.35M | Sell |
6,624
-6,483
| -49% | -$1.4M | 0.04% | 360 |
|
|
2025
Q4 | $2.69M | Buy |
13,107
+265
| +2% | +$49.9K | 0.08% | 190 |
|
|
2025
Q3 | $2.02M | Buy |
12,842
+10,203
| +387% | +$1.58M | 0.03% | 462 |
|
|
2025
Q2 | $443K | Buy |
2,639
+131
| +5% | +$19.4K | 0.02% | 422 |
|
|
2025
Q1 | $346K | Buy |
2,508
+1,779
| +244% | +$227K | 0.02% | 387 |
|
|
2024
Q4 | $86.2K | Sell |
729
-23
| -3% | -$2.69K | 0.01% | 724 |
|
|
2024
Q3 | $83.1K | Buy |
752
+84
| +13% | +$8.78K | 0.01% | 543 |
|
|
2024
Q2 | $65.6K | Buy |
668
+3
| +0.5% | +$306 | 0.01% | 573 |
|
|
2024
Q1 | $74.4K | Buy |
665
+24
| +4% | +$2.59K | 0.01% | 428 |
|
|
2023
Q4 | $64.6K | Buy |
641
+7
| +1% | +$695 | 0.01% | 430 |
|
|
2023
Q3 | $55.1K | Buy |
634
+3
| +0.5% | +$271 | 0.01% | 452 |
|
|
2023
Q2 | $59.7K | Buy |
631
+4
| +0.6% | +$338 | 0.01% | 438 |
|
|
2023
Q1 | $47.4K | Buy |
627
+4
| +0.6% | +$302 | 0.01% | 472 |
|
|
2022
Q4 | $47.9K | Sell |
623
-12
| -2% | -$912 | 0.01% | 453 |
|
|
2022
Q3 | $42K | Buy |
635
+5
| +0.8% | +$317 | 0.01% | 454 |
|
|
2022
Q2 | $33K | Sell |
630
-243
| -28% | -$13.8K | 0.01% | 483 |
|
|
2022
Q1 | $49K | Buy |
873
+8
| +0.9% | +$428 | 0.01% | 454 |
|
|
2021
Q4 | $45K | Buy |
865
+8
| +0.9% | +$392 | 0.01% | 473 |
|
|
2021
Q3 | $42K | Buy |
857
+7
| +0.8% | +$380 | 0.01% | 477 |
|
|
2021
Q2 | $49K | Buy |
+850
| New | +$49.7K | 0.01% | 472 |
|
|
2020
Q4 | $45K | Buy |
836
+8
| +1% | +$415 | 0.01% | 423 |
|
|
2020
Q3 | $39K | Buy |
828
+43
| +5% | +$2.21K | 0.01% | 414 |
|
|
2020
Q2 | $41K | Buy |
785
+8
| +1% | +$412 | 0.01% | 393 |
|
|
2020
Q1 | $37K | Buy |
777
+7
| +0.9% | +$363 | 0.01% | 387 |
|
|
2019
Q4 | $39K | Buy |
770
+8
| +1% | +$413 | 0.01% | 363 |
|
|
2019
Q3 | $36K | Buy |
762
+8
| +1% | +$365 | 0.01% | 365 |
|
|
2019
Q2 | $36K | Buy |
+754
| New | +$34.8K | 0.01% | 361 |
|
|
2018
Q4 | $48K | Buy |
1,068
+10
| +0.9% | +$521 | 0.02% | 275 |
|
|
2018
Q3 | $57K | Buy |
+1,058
| New | +$54.1K | 0.02% | 266 |
|
Other funds holding CAH
Arax Advisory Partners's CAH Position: Q2 2026 in Review
Arax Advisory Partners increased its Cardinal Health (CAH) stake by 238% in Q2 2026, buying an estimated $3.27M and bringing the position to 22,382 shares worth $5.32M. The position accounts for 0.04% of the portfolio, ranked #468.
Arax Advisory Partners first reported a position in CAH in Q3 2018 and has held it in 30 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Arax Advisory Partners held 22,382 shares of Cardinal Health worth $5.32M as of Q2 2026.
- Arax Advisory Partners bought 15,758 Cardinal Health shares in Q2 2026, an estimated $3.27M.
- Cardinal Health made up 0.04% of Arax Advisory Partners's portfolio in Q2 2026, its #468 holding.
- Arax Advisory Partners first reported a position in Cardinal Health in Q3 2018 and has held it in 30 quarters since.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.